S&P 500 7,659.44 −1.09%
Nasdaq 26,140.03 −2.15%
S&P/TSX 36,176.55 +0.11%
Apple 343.46 +0.43%
Nvidia 214.13 −1.43%
Microsoft 529.05 −1.93%
Shopify 239.71 −5.08%
Royal Bank 280.01 +0.36%
CAD/USD 0.7074 +0.40%
AFTER HRS · 19:55 ET
Market ClerkRecap
Fri Oct 16 · after hours3 signals today88 insider buys this week · $104.3MCIRO short report next: Oct 31The week ahead
BM
INSIDER · PTCT · PTC THERAPEUTICS, INC. · EXEC. VP AND CLO

Boulding Mark Elliott

Every open-market transaction filed under this name, Oct 5 to Oct 9.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$145K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 9PTCTPTC THERAPEUTICS, INC.EXEC. VP AND CLOSell192$64.26$12K−7.8%
Oct 6PTCTPTC THERAPEUTICS, INC.EXEC. VP AND CLOSell435$64.16$28K−7.7%
Oct 5PTCTPTC THERAPEUTICS, INC.EXEC. VP AND CLOSell1,638$64.03$105K−7.5%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.